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By the year 2000 the total human population passed the 6 billion
mark. It is estimated to peak at 9 billion around 2070 before
declining to 8.4 billion at the end of the century.  The decline will
largely be due to reduced fertility rates, improved health care and
quality of life.  However, currently the proportion of elderly (i.e.
over 60 years of age) is 10%; this is expected to reach 34% by
2100.
Life expectancy in the USA has reached 78 and 80 years for white
men and women, respectively – figures barely achieved by those
South Africans who manage to reach the age of 60.  Non-commu-
nicable diseases that cause premature death are cardiovascular
disease, cancer, respiratory disease and the dementias.  These dis-
eases in turn are greatly influenced by our state of nutrition (under-
nutrition, malnutrition, obesity), physical activity and substance
abuse (alcohol, cigarettes, drugs).
1
Longstanding disability before death has become an increasingly
important social and national health problem and we thus distin-
guish between life expectancy (longevity) and healthy life expectan-
cy (number of years that we live without disability).  The two are
inter-related.  In general, years of healthy life lost because of dis-
ability amount to 8% in Western countries as opposed to 18% in
developing countries.  Interestingly, increased health expenditure
per capita increases healthy life expectancy more than total life
expectancy.
1
Disability and ageing in
turn have an impact on
each other and it is increas-
ingly clear that the two pre-
viously opposing sets of
hypotheses on the cause of
ageing, namely the 'genet-
ic' theories and the ‘envi-
ronmental’ theories, are
interconnected and may be
regarded as comprising dif-
ferent aspects of the same
phenomenon.
GENETIC THEORIES
Most ageing research is
conducted in rodents
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because methodological obstacles limit
the study of DNA and RNA obtained
from human brain tissue.  Therefore the
role of genetic regulation on human
brain ageing and the effect of ageing
on genetic function are not clear.  The
genetic theories hypothesise ageing as
the consequence of somatic mutations,
multiple genetic errors and pro-
grammed cell death.
Programmed cell death (apoptosis)
states that a cell can only divide a limit-
ed number of times before death.  Cells
that regenerate and then die are simi-
larly restricted.  In 1961 Hayflick and
Moorhead discovered that human fetal
fibroblasts will double about 50 times
before dying.
2
Further, this is species
specific and  correlates with the
longevity of the animal. For example,
fibroblasts from a mouse embryo (life
span 3 years) divide about 15 times
and those from the Galapagos tortoise
(life span 175 years) about 90 times.
3
Genetic studies of the nematode worm
Caenorhabditis elegans have provided
key insights.  This small, soil-dwelling
worm consists of a fixed number of
cells (959 in the hermaphrodite and 
1 031 in the male form) and has
recently had its entire genome
sequenced.
3,4
About 15% of its identi-
fied cells, most of them neurons, under-
go programmed cell death and about a
dozen cell death genes are known to
control apoptosis.
4
Several groups of
workers have bred long-lived strains
with mean increases in life span of up
to 70%.
2
This type of apoptosis under-
lies the death of all cells.
4
At the other end of the spectrum, accel-
erated ageing featuring in all organ
systems is found in Hutchinson-Gilford
progeria and Werner's syndrome.
Progeria is a rare syndrome occurring
in 1 in 8 million individuals.  Affected
patients survive until around the age of
12 years.  Most victims (80%) die of
myocardial infarctions caused by dis-
seminated atherosclerosis.  While nor-
mal intellect is retained, these children
commonly manifest cataracts, balding,
osteoporosis and neoplasms.
5
The
retention of intellect suggests that
dementia may not be a necessary con-
sequence of ageing or that a more pro-
longed time period is required for
dementia to express itself.  Cell lines
from patients suffering from either syn-
drome have diminished replicative life
spans.  Both diseases implicate a loss-
of-function mutation in a gene that
encodes a DNA helicase and both con-
ditions produce excessive concentra-
tions of hyaluronic acid.
2,4,5
ENVIRONMENTAL THEORIES
Life-span studies suggest that heritability
accounts for less than 35% of variance
in longevity, while human twin studies
show that non-shared environmental
factors account for over 65% of vari-
ance.
5
Studies on rodents show that a 40%
reduction in caloric intake will extend
life span by 40 - 50%.  Diminished
feeding of rodents not only slows age-
ing but prolongs the reproductive life
span.  Such dietary restrictions are
thought to lower oxidative stress by
slowing metabolism.
5
Oxidative damage is produced by
extrametabolic insults (e.g. smoking,
pollution and radiation) or intrinsic
metabolic sources.  Approximately 
2 - 3% of oxygen consumed by cells
results in oxygen-free radicals.
5,6
Free
radicals form part of reactive oxygen
species (ROS), a collective group of
oxygen compounds.  Among these the
hydroxyl radical initiates a detrimental
chain reaction in membranes, called
lipid peroxidation.  The hydroxyl radi-
cal may also react with protein mole-
cules in the cell membrane causing
fragmentation, increased susceptibility
to proteolysis and crosslinking.
6
Nuclear DNA and mitochondrial DNA
are also susceptible and the net result is
that oxidative stress may contribute to
ageing and neurodegenerative
disease.
5,6
Efficient antioxidant defence systems
mop up the harmful chemicals in order
to achieve some balance and to protect
at least partially against ROS damage.
These defences include metal chelators
(e.g. transferrin and melatonin),
enzymes (e.g. superoxide dismutase
and catalase) and antioxidant nutrients
(e.g. vitamins A, C, E and beta-
carotene).
6
Healthy ageing may therefore require a
proper balance of free radical produc-
tion and detoxification.  Oxidative
stress may result from increased sensi-
tivity to free radical damage,
decreased antioxidant protection,
altered calcium homeostasis or an
impaired ability to repair the damage.
5
THE DEMENTIAS
The presence of dementia predicts
poor 7-year survival after age 85.  The
neuropathological distinctions between
'normal' ageing and disease are fre-
quently obscure, and some neu-
ropathologists have proposed a contin-
uum from normal ageing through
pathological ageing to disease states.
5
For example, neurofibrillary tangles,
senile plaques, amyloid deposits, and
cholinergic deficits were considered
disease markers until studies demon-
strated similar alterations in some cog-
nitively intact elderly humans.
5
In the USA Alzheimer's disease (AD)
ranks as the fourth leading cause of
death in adults, after heart disease,
cancer and stroke. The risk for demen-
tia increases dramatically with age.
Over half of the dementias in elderly
Western populations are attributable to
AD with a prevalence of approximately
6.2% over age 65, 20% over 80, and
45% over 95 years of age.
Monozygotic twin studies show that
when one twin develops AD, approxi-
mately 40% of the co-twins also devel-
op the disorder.  Often, however, there
is a long delay before the second twin
is affected, suggesting both environ-
mental and genetic contributions to the
disorder.
7
AD, AD with cerebrovascular disease
and vascular dementia (VaD) account
for over 90% of the dementias.  We
also know that there is a strong associ-
ation between the risk factors for 
cardiovascular disease and the above-
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mentioned dementias.  The cardiovas-
cular risk factors, in turn, include
hypertension, diabetes, hyperlipi-
daemia and smoking (Table I).
Atherosclerosis, common to both AD
and VaD, should be regarded as an
inflammatory systemic disease with
many different manifestations, e.g.
claudication, ischaemic heart disease
or cognitive impairment, and should
therefore be treated vigorously.
8
Systemic atherosclerosis begins in the
second decade of life (5% of the popu-
lation affected) and accelerates after
the third decade.  Less than 4% of 90-
year-olds escape atherosclerotic change
in their cardiovascular system.
9
Atherosclerosis predisposes to AD and
the prevalence of AD rises with the
degree of atherosclerosis. There is also
an interaction between atherosclerosis
and apo E-4 in the development of
AD.
8
In the penetrating vessels of the brain
the vascular endothelial lining is affect-
ed and in turn responsible for free radi-
cal production, perivascular inflamma-
tion, disrupted nutrient supply and
selective neuronal (i.e. cholinergic,
because of greater vulnerability than
other neurons) death with resultant cog-
nitive decline, a situation aggravated
by low thiamine levels.
10
This subcorti-
cal microvascular pathology not only
provides a common substrate for AD,
AD and cerebrovascular disease, and
VaD, but also clinically manifests mild
degrees of AD pathology which, on its
own, would have remained asympto-
matic.
11,12
Since atherosclerosis has a complex
pathogenesis which includes, among
others hyperlipidaemia, diabetes,
hypertension and elevated platelet num-
bers, lipid-lowering agents play a
major role at this level.  Apart from
their lipid-lowering effect, statins reduce
membrane lipid peroxidation by
decreasing free radical production and
vascular inflammation.  The overall net
effect of lipid-lowering agents is the
reduction of cholesterol, atherosclerotic
plaques and plaque rupture, and
improved endothelial function and
blood flow.  The Canadian Study of
Health and Ageing (CSHA) showed
that the clinical use of lipid-lowering
agents was associated with a lower risk
of dementia, specifically AD.
13
Other measures delaying the onset of
AD or slowing down its course include:
• low-dose anti-inflammatories, e.g.
ibuprofen 200 mg several times a
week
14
• red wine (approximately 250 - 500
ml per day, most likely because of
ingredients such as resveratrol)
15
• intellectual stimulation and higher
education – thought to improve the
number of synapses, thus creating
greater reserves
14
• hormone replacement therapy (initiat-
ed perimenopausally where indicated
and restricted to oestrogen)
14
• vitamin E (more than 400 IU) in com-
bination with vitamin C (500 mg or
more) daily, – associated with a
reduced prevalence and incidence of
AD.
16
While the effect of chronic physical
and emotional stress on ageing is
unclear, elevated glucocorticoids are
toxic to rodent hippocampal neurons5
and oxidative stress is increasingly
being linked to ageing of the brain and
neuropathogenesis.
6,16
General lifestyle measures associated
with healthy ageing therefore include:
1,5
• good sleep
• regular physical activity (enhances
brain vascularity)
• cessation of smoking
• reduced salt intake
• ingestion of seafood
• olive oil/Mediterranean diet
• diet rich in vegetables and fruit and
low in animal proteins and fats.
References available on request.
• Hypertension – note age-acceptable
blood pressure
• Diabetes mellitus – note age-accept-
able blood glucose levels
• Platelet aggregation – aspirin 80 -
150 mg a day
• Hyperlipidaemia – dietary modifica-
tions and lipid-lowering agents, e.g.
statins12,13
• Smoking – should be stopped
• Alcohol – reduce to an equivalent
maximum of three tots of spirits a
day
• Body mass index – dietary modifi-
cation and regular exercise
• Endothelial stress and inflammation
– thiamine10
• Hyperhomocysteinaemia – folic
acid, vitamins B6 and B1212
Table I. Control of cardiovas-
cular risk factors
Our current population of elderly is
steadily increasing as is the popula-
tion's life expectancy (longevity),
although not necessarily the healthy
life expectancy (years lived without
disability).
Life-span studies suggest that heri-
tability accounts for less than 35% of
variance in human survival duration.
Therefore 'genetic' theories and
'environmental' theories of ageing
are interlinked and may be regarded
as comprising different aspects of the
same phenomenon.
The genetic theories hypothesise age-
ing as the consequence of somatic
mutations, multiple genetic errors
and programmed cell death, while
environmental theories focus on
oxidative stress resulting from
microvascular pathology (especially
in the brain) and lifestyle. 
Cardiovascular risk factors are para-
mount in the production of athero-
sclerosis which determines the
degree of disability and the expres-
sion of dementia.
Lifestyle changes concentrating on
cardiovascular risk factors are recog-
nised as delaying the onset and
severity of dementias such as
Alzheimer's disease as well as reduc-
ing disability.
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